Concepedia

Fenfang Zhou

FZ

Statistics

Publications

23

Citations

636

H-Index

15

Active since

2017

Affiliations

Zhongnan Hospital of Wuhan University(Current)

Wuhan University

Euler Technology (China)

Wuhan Institute of Virology

Wuhan Center for Disease Control and Prevention

Fenfang Zhou is an author at Zhongnan Hospital of Wuhan University specializing in medicine, oncology, and molecular oncology.

Publications per year

2017–2025

23

Publications

23

ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis

Liang Chen, Tianchen Peng, Yongwen Luo et al. · Frontiers in Oncology · 2019 · 63 citations · Full text

, , +17

NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation

Peng Zhang, Liang Chen, Fenfang Zhou et al. · Cell Death and Disease · 2023 · 61 citations · Full text

, , +17

E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability

Huimin Xu, Lingao Ju, Yaoyi Xiong et al. · Cell Death and Disease · 2021 · 54 citations · Full text

, , +17

SLC38A1 promotes proliferation and migration of human colorectal cancer cells

Fenfang Zhou, Wei Xie, Shuangqian Chen et al. · Journal of Huazhong University of Science and Technology [Medical Sciences] · 2017 · 49 citations

, , +12

UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT

Wenzhi Du, Sheng Tu, Wenxiu Zhang et al. · International Journal of Biological Sciences · 2024 · 48 citations · Full text

, , +16

1–5 of 23